knowledge -WSS

knowledge

author：explore 2025-09-28 23:29:26 - browse：7831

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： CRISPR gene editing developments we’re watching in 2024

explore

WSS

Truvian presents data for its desktop blood

In Spain, a hospital brews its own CAR

Virtual care provider acquires bankrupt Pear's prescription apps

Keeping primary care docs in field isn't impossible, says AAFP CEO

Senate panel puts off hardest PBM reforms for another day

Albert Bourla of Pfizer: worst biopharma CEO of 2023

explore

knowledge

knowledge

At least 13 dead in Texas as scorching temps continue

Three trends to watch in biotech in 2024

Guidelines to prevent youth baseball injuries need more muscle

CDC Director Mandy Cohen on transparency, trust, and health

Anesthesiologist group: stop taking Ozempic before surgery

Medicare Advantage beneficiaries sue Humana over algorithm use

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Why patients can’t get everything they want on drug pricing

United colonoscopy coverage change 'may cost lives,' doctors say

Violet CEO on training clinicians to promote more inclusive care

hotspot

CDC Director Mandy Cohen on transparency, trust, and health

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Democrats decry new health bill for going easy on private equity

What to watch for from Zogenix and Amicus clinical trials

The battle over 'scope creep' and who gets to be called 'doctor'

Former reverend arrested for allegedly killing 8

hotspot

entertainment

explore

entertainment